Editorial: Emerging therapies for metabolic bone diseases - Takeaways - MDSpire

Editorial: New Treatment Approaches for Metabolic Bone Disorders

  • By

  • Alberto Falchetti

  • Luigi Gennari

  • July 17, 2026

Share

  • 1

    The field of metabolic bone diseases is evolving due to advances in molecular biology and targeted therapies.

  • 2

    Zoledronic acid has established antifracture efficacy, particularly in postmenopausal women with osteopenia.

  • 3

    Burosumab has emerged as an effective targeted therapy for X-linked hypophosphatemia and tumor-induced osteomalacia.

  • 4

    Vitamin D analogues like doxercalciferol are being explored for their potential in bone and calcium homeostasis.

  • 5

    Patient-reported outcomes highlight the ongoing symptom burden in chronic hypoparathyroidism despite standard therapies.

Original Source(s)

Editorial: Emerging therapies for metabolic bone diseases

  • by Alberto Falchetti, Luigi Gennari

  • July 17, 2026

Related Content

Biological Retinal Age Predicts Fractures

New study says AI-based retinal imaging has potential to be used as a screening tool for osteoporosis risk

  • June 22, 2026

  • 3 min
Unveiling the efficacy predictors and potential mechanisms of Semen Cuscutae against osteoporosis via machine learning and meta-analysis: a preclinical study

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.